Factors Associated with Prevalent Tuberculosis Among Patients Receiving Highly Active Antiretroviral Therapy in a Nigerian Tertiary Hospital

Author(s):

Iroezindu MO, Iroezindu MO, Iroezindu MO, Iroezindu MO*, Mbata GC, Wyk B, Hausler HP, Au DH, Lynen L and Hopewell PC

Background: Tuberculosis (TB) causes significant morbidity/mortality among human immunodeficiency virusâÃ?Â?Ã?Â?infected individuals in Africa. Reducing TB burden in the era of highly active antiretroviral therapy (HAART) is a public health priority. Aim: We determined the factors associated with prevalent TB among patients receiving HAART. Subjects and Methods: We conducted a crossâÃ?Â?Ã?Â?sectional study of adult patients who had received HAART for ≥12 weeks in a Nigerian tertiary hospital. Patients whose TB diagnosis predated HAART were excluded from the study. PreâÃ?Â?Ã?Â?HAART data were collected from the clinic records, whereas postâÃ?Â?Ã?Â?HAART data were obtained through medical history, physical examination, and laboratory investigations. Standard TB screening/diagnostic algorithms as applicable in Nigeria were used. Logistic regression analysis was used to determine factors independently associated with prevalent TB. Results: about 65.8% (222/339) were women. The mean age was 41.1 (10.0) years and 23.6% (73/339) had past history of TB. The prevalence of active TB was 7.7% (26/339). Among these patients, 42.3% (11/26) had pulmonary TB, 34.6% (9/26) had disseminated TB, whereas 23.1% (6/26) had only extraâÃ?Â?Ã?Â?pulmonary disease. Only 45% (9/20) of patients with pulmonary involvement had positive sputum smear. Factors independently associated with prevalent TB were lower social class (adjusted odds ratio [aOR]: 31.7; 95% confidence interval [CI]: 1.1–1417.3), HAART nonâÃ?Â?Ã?Â?adherence (aOR125.5; 95% CI: 9.6–1636.3), baseline CD4 <200cells/μl (aOR31.0; 95%CI: 1.6–590.6), previous TB (aOR13.8; 95% CI: 2.0–94.1), and current hemoglobin <10 g/dl (aOR10.3; 95% CI: 1.1–99.2). Conclusion: Factors associated with prevalent TB were a lower social class, HAART nonâÃ?Â?Ã?Â?adherence, severe immunosuppression before HAART initiation, previous TB, and anemia postâÃ?Â?Ã?Â?HAART. TB case finding should be intensified in these highâÃ?Â?Ã?Â?risk groups.